Equities

JCR Pharmaceuticals Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

JCR Pharmaceuticals Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)614.00
  • Today's Change20.00 / 3.37%
  • Shares traded2.55m
  • 1 Year change-1.13%
  • Beta0.3739
Data delayed at least 15 minutes, as of Jul 11 2025 07:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JCR Pharmaceuticals Co., Ltd. is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Company operates in two segments. The Pharmaceutical segment engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment segment engages in the purchase and sale of the medical and research equipment.

  • Revenue in JPY (TTM)33.07bn
  • Net income in JPY-4.76bn
  • Incorporated1975
  • Employees987.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Cuorips Inc175.21m-644.34m50.15bn56.00--9.05--286.21-80.64-80.6421.89682.900.02940.2992.193,128,661.00-10.82---11.15--96.03---368.32--28.65-17.490.00--658.40---1.92------
ASKA Pharmaceutical Holdings Co Ltd64.14bn5.10bn67.79bn1.63k13.101.029.231.06179.94179.942,262.572,302.590.67061.404.1839,300,860.005.335.507.267.0748.8647.567.957.981.39--0.136116.602.064.07-32.3951.049.4931.48
JCR Pharmaceuticals Co Ltd33.07bn-4.76bn79.63bn987.00--1.59--2.41-38.86-38.86267.09386.120.31940.53092.4333,507,600.00-4.545.86-7.109.3365.7373.83-14.2013.600.666-26.060.446645.13-22.865.94-186.42--15.3720.11
Nxera Pharma Co Ltd30.87bn-2.32bn79.82bn374.00--1.1845.202.59-25.83-25.83343.68746.050.20721.486.9682,534,760.00-1.56-1.71-1.72-1.8573.9584.07-7.51-10.933.11--0.497--125.8724.2832.74--40.57--
Katakura Industries Co Ltd40.12bn3.92bn87.19bn941.0020.540.938412.532.17120.54120.541,233.122,638.590.28852.324.7642,634,430.002.972.603.663.5737.0137.9810.299.442.55--0.094723.42-1.37-2.1915.7315.27-7.2233.03
Kyorin Pharmaceutical Co Ltd130.09bn9.09bn89.92bn2.00k9.480.63236.570.6912158.16158.162,264.402,372.280.70081.182.7865,108,610.004.893.346.254.1645.7745.896.985.112.01--0.172757.348.833.4170.738.1214.36-7.06
Mochida Pharmaceutical Co Ltd105.16bn5.69bn105.82bn1.51k18.130.788812.271.01160.36160.362,966.323,686.670.65951.623.1669,734,090.003.574.504.245.4451.1552.495.416.873.4740.430.002643.012.210.651625.034.341.980.00
Zeria Pharmaceutical Co Ltd87.31bn9.94bn108.95bn1.75k9.101.016.221.25225.42225.421,980.762,031.330.56381.513.7050,006,380.006.444.679.957.4773.2572.1711.429.020.9752--0.320928.7515.307.6428.5227.7116.516.69
Data as of Jul 11 2025. Currency figures normalised to JCR Pharmaceuticals Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.88%Per cent of shares held by top holders
HolderShares% Held
Nomura Asset Management Co., Ltd.as of 14 Feb 20255.53m4.26%
The Vanguard Group, Inc.as of 02 Jul 20252.57m1.98%
Norges Bank Investment Managementas of 31 Dec 20241.87m1.44%
Nikko Asset Management Co., Ltd.as of 04 Jul 2025985.60k0.76%
Daiwa Asset Management Co. Ltd.as of 30 May 2025954.80k0.74%
PineBridge Investments Japan Co., Ltd.as of 31 Dec 2024581.90k0.45%
Tokio Marine Asset Management Co., Ltd.as of 20 Jun 2024555.60k0.43%
Mitsubishi UFJ Asset Management Co., Ltd.as of 03 Jul 2025420.20k0.32%
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 03 Jul 2025365.10k0.28%
Aviva Investors Global Services Ltd.as of 30 May 2025284.40k0.22%
More ▼
Data from 31 Dec 2024 - 31 Mar 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.